|
|
Volumn 298, Issue 15, 2007, Pages 1747-1749
|
|
Scientists examine benefits, risks of treating preschoolers with ADHD drugs
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
METHYLPHENIDATE;
NEUROTRANSMITTER;
PLACEBO;
PSYCHOTROPIC AGENT;
ALLELE;
ATTENTION DEFICIT DISORDER;
BEHAVIOR DISORDER;
BRAIN;
BRAIN FUNCTION;
CHILD GROWTH;
CLINICAL TRIAL;
DECREASED APPETITE;
DOPAMINERGIC SYSTEM;
DRUG DOSE TITRATION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG WITHDRAWAL;
EMOTIONAL DISORDER;
GROUPS BY AGE;
HUMAN;
IRRITABILITY;
NEUROIMAGING;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OUTCOME ASSESSMENT;
PATIENT MONITORING;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SCIENTIST;
SHORT SURVEY;
SIDE EFFECT;
SLEEP DISORDER;
|
|
EID: 35348981180
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.298.15.1747 Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|